After years of delays and rising costs, AstraZeneca has formally unveiled its $1 billion R&D facility in Cambridge ... could one day become a biotech hub to rival Boston and San Francisco in ...

The Cambridge Independent Business Awards 2025 are now open for entry. Following the success of our inaugural awards last year, we are delighted to announce that the search is now on for the best in ...

The signatories, who include AstraZeneca's head of discovery sciences Steve Rees and the vice-chancellors of the universities of Oxford and Cambridge ... than any other hub in the world, the ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

Multinationals on China: China has set a GDP growth target of around 5% for 2025. How do you view this target and China’s ...

The biopharma’s planned R&D center in Cambridge—which is the home of AstraZeneca and already a U.K. biotech hub in its own right—will have space for around 90 scientists and focus on ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises. See why AZN stock is a Buy.

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca will present the latest clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American ...

Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

A Google Translate screenshot correctly shows that the name of the pharmaceutical company AstraZeneca, when written as “A stra ze neca,” means “a road to death” in Latin. We reached out to ...